Cytogenetic study of 30 patients with multiple myeloma: Comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karotypic method

British Journal of Haematology

Volumn 96, Issue 3, 1997, Pages 594-600

  Brigaudeau, Christophe ^a   Trimoreau, Frank ^a   Gachard, Nathalie ^a   Rouzier, Evelyne ^a   Jaccard, Arnaud ^a   Bordessoule, Dominique ^a   Praloran, Vincent ^a,b  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Culture; Cytogenetics; Cytokines; Multiple myeloma; Plasma cells

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KARYOTYPING; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; TECHNIQUE;

BONE MARROW; BONE MARROW DISEASES; CELL DIVISION; CHROMOSOME ABERRATIONS; CYTOGENETICS; CYTOKINES; FEMALE; HUMANS; KARYOTYPING; MALE; MITOSIS; MULTIPLE MYELOMA; PLASMA CELLS;

EID: 0031029588     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-2073.x     Document Type: Article

References (30)

1. Bakkus, M., Van Riet, I., De Greef, C., Van Camp, B. & Thielemans, K. (1995) The clonogenic precursor cell in multiple myeloma. Leukemia and Lymphoma, 18, 221-229.
2. Banchereau, J. (1990) Interleukine 4. Medecine Sciences, 6, 946.
3. Banchereau, J. & Rousset, F. (1991) Function of interleukin-4 on human B lymphocytes. Immunology Research, 10, 423-427.
4. Billadeau, D., Quam, L., Thomas, W., Kay, N., Greipp, P., Kyle, R., Oken, M.N. & Van Ness, B. (1992) Detection and quantification of malignant cells in the peripheral blood of multiple myeloma patients. Blood, 80, 1818-1824.
5. Brigaudeau, C., Gachard, N., Clay, D., Fixe, P., Rouzier, E. & Praloran, V. (1996) A 'miniaturized' method for the karyotypic analysis of bone marrow or blood samples in hematological malignancies. Hematology and Cell Therapy, 38, 275-277.
6. Carter, A., Merchav, S., Silvian-Draxler, I. & Tatarsky, I. (1990) The role of interleukin-1 and tumour necrosis factor-α in human multiple myeloma. British Journal of Haematology, 74, 424-431.
7. Cigudosa, J.C., Calasanz, M., Odero, D., Prosper, F. & Rocha, E. (1994) Cytogenetic data in 41 patients with multiple myeloma. Cancer Genetics and Cytogenetics, 78, 210-213.
8. Dewald, G.W., Kyle, R., Hicks, G. & Greipp, P. (1985) The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia or amyloidosis. Blood, 66, 380-390.
9. Drach, J., Schuster, J., Nowotny, H., Angerler, J., Rosenthal, F., Fiegl, M., Rothermundt, C., Gsur, A., Jäger, U., Heinz, R., Lechner, K., Ludwig, H. & Huber, H. (1995) Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Research, 55, 3854-3859.
10. Durie, B.G. & Salmon, S.E. (1976) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer, 36, 842-854.
11. Facon, T., Lai, J.L., Preudhomme, C., Zandecki, M. & Bauers, F. (1993) Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients. British Journal of Haematoloay, 84, 743-745.
12. Ferti, A., Panani, A., Arapakis, G. & Raptis, S. (1984) Cytogenetic study in multiple myeloma. Cancer Genetics and Cytogenetics, 12, 247-253.
13. Gould, J., Alexanian, R., Goodacre, A., Pathak, S., Hecht, B. & Barlogie, B. (1988) Plasma cell karyotype in multiple myeloma. Blood, 71, 435-456.
14. Greipp, R., Lust, J., O'Fallon, M., Katzmann, J., Witzig, T. & Kyle, R. (1993) Plasma cell labelling index and β2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood, 81, 3382-3387.
15. Gutensohn, K., Weh, H.J., Walter, T.A. & Hossfeld, D.K. (1992) Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients. Annals of Hematology, 65, 88-90.
16. Klein, B., Zhang, X.G., Lu, Z.Y. & Bataille, R. (1995) Interleukin 6 in human multiple myeloma. Blood, 85, 863-872.
17. ISCN (1995) Guidelines for Cancer Cytogenetics. Supplement to: An International System for Human Cytogenetic Nomenclature (ed. by T. Mitelman). Karger, Basel.
18. Lai, J.L., Zandecki, M., Mary, J.Y., Bernardi, F., Izidorczyk, V., Flactif, M., Morel, P., Jouet, J.P., Bauters, F. & Facon, T. (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 at diagnosis. Blood, 9, 2490-2497.
19. Meeus, P., Stul, M.S., Mecucci, C., Cassiman, J.J. & Van Der Berghe, H. (1995) Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma. Cancer Genetics and Cytogenetics, 83, 25-27.
20. Mugneret, F., Sidaner, L., Favre, B., Manone, L., Maynadie, M., Caillot, D. & Solary, E. (1995) Der(16)t(1;16)(q10;p10) in multiple myeloma: a new nonrandom abnormality that is frequently associated with Burkitt's type translocation. Leukemia, 9, 277-281.
21. Pilarski, L.M., Mant, M.M. & Belch, A.J. (1994) Circulating, monoclonal, multidrug resistant B cells may comprise the malignant stem cell population in multiple myeloma. Challenges of Modern Medicine (ed. by F. Barlogie), Vol. 4, pp. 31-42. Ares Sereno Symposia Publications.
22. Sawamura, M., Murakami, H., Tamura, J., Matsuhima, T., Sato, S., Naruse, T. & Tsuchiya, J. (1994) TNF and IL4 promote the differentiation of myeloma cell precursors in multiple myeloma. British Journal of Haematology, 88, 17-23.
23. Sawyer, J.R., Waldron, J.A., Jagannth, S. & Barlogie, B. (1995) Cytogenetic finding in 200 patients with multiple myeloma. Cancer Genetics and Cytogenetics, 82, 41-49.
24. Smadja, N.V., Louvet, C., Isnard, F., Dutel, J.L., Grange, M.J., Varette, C. & Krulik, M. (1995) Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques. British Journal of Haematology, 90, 619-624.
25. Van Riet, I., Bakkus, M., De Greef, C., Paid, L. & Van Camp, B. (1995) Homing mechanisms in the ethiopathogenesis of multiple myeloma. Stem Cells, 13, (Suppl. 2), 22-27.
26. Weh, H.J., Gutensohn, K., Selbach, J., Kruse, R. & Hossfeld, D.K. (1993) Karyotype in multiple myeloma and plasma cell leukaemia. European Journal of Cancer, 29A, 1269-1273.
27. Witzig, T.E. (1994) Detection of malignant cells in the peripheral blood of patients with multiple myeloma: clinical implications and research applications. Mayo Clinic Proceedings, 69, 903-907.
28. Zandecki, M., Bernardi, F., Lai, J.L., Facon, T., Izydorczyk, V., Bauters, F. & Cosson, A. (1994) Image analysis in multiple myeloma at diagnosis: correlation with cytogenetic study. Cancer Genetics and Cytogenetics, 74, 115-119.
29. Zandecki, M., Lai, J.L. & Facon, T. (1996) Multiple myeloma: almost all patients are cytogenetically abnormal. British Journal of Haematology, 94, 217-227.
30. Zhang, X.G., Bataille, R., Jourman, M., Saelano, S., Banchereau, J., Mannoni, P. & Klein, B. (1990) Granulocyte macrophage colony stimulating factor synergizes with IL-6 in supporting the proliferation of human myeloma cells. Blood, 76, 2599-2605.